<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01870544</url>
  </required_header>
  <id_info>
    <org_study_id>Tufts Obesity Study</org_study_id>
    <nct_id>NCT01870544</nct_id>
  </id_info>
  <brief_title>Does Weight Loss Surgery and Probiotic Supplementation Lead to a &quot;Lean&quot; Gut Microbiota?</brief_title>
  <official_title>Does Weight Loss Surgery and Probiotic Supplementation Lead to a &quot;Lean&quot; Gut Microbiota?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tufts Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tufts Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the weight-loss study is to characterize the effect of LGG supplementation on&#xD;
      the relative abundance of phyla in the gut microbiota of patients undergoing gastric bypass&#xD;
      and sleeve gastrectomy surgery, and to elucidate a relationship between the gut microbiota&#xD;
      pattern and the degree of weight-loss post-surgery.&#xD;
&#xD;
      The investigators hypothesize that LGG administration will result in a &quot;leaner&quot; pattern of&#xD;
      gut microbiota that will lead to higher weight loss at 3 months post-surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Weight Loss</measure>
    <time_frame>4 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Bacteria Phyla</measure>
    <time_frame>4 months</time_frame>
    <description>We will specifically look at the percentages of different bacterial phyla in the stool and intestine</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>LGG Administration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lactobacillus Rhamnosus GG (LGG) will be taken orally for 44 days. The daily dose is 2*10^10 organisms. The LGG is contained in capsules (1*10^10 organisms per capsule), and two capsules will be taken per day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo to be taken orally for 44 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lactobacillus Rhamnosus GG</intervention_name>
    <description>LGG will be administered orally for 44 days</description>
    <arm_group_label>LGG Administration</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>placebo will be administered daily for 44 days</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age greater than or equal to 18 years&#xD;
&#xD;
          2. Able to give informed consent and report on side effects&#xD;
&#xD;
          3. Tolerating an oral/enteral diet&#xD;
&#xD;
          4. Stable comorbid conditions&#xD;
&#xD;
          5. Outpatient&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Inpatients&#xD;
&#xD;
          2. Pregnancy (urine test done on all patients routinely pre-op)/ unwilling to comply with&#xD;
             contraceptive requirement after gastric bypass surgery&#xD;
&#xD;
          3. Known use of LGG or another probiotic (not including yogurt) within the previous 30&#xD;
             days&#xD;
&#xD;
          4. Presence of an active bowel leak, acute abdomen, active intestinal disease, or&#xD;
             significant bowel dysfunction&#xD;
&#xD;
          5. Presence of an absolute neutrophil count less than 500 per cubic mm (must have had a&#xD;
             Complete Blood Count within the last 6 months) or anticipation post chemotherapy that&#xD;
             the absolute neutrophil count will fall below 500 per cubic mm.&#xD;
&#xD;
          6. History of adverse reaction to product containing lactobacillus&#xD;
&#xD;
          7. Active colitis (*see definition below)&#xD;
&#xD;
          8. Known or suspected allergies to probiotics, lactobacillus, milk protein, or&#xD;
             microcrystalline cellulose&#xD;
&#xD;
          9. Structural heart disease, history of endocarditis or valve replacement, implanted&#xD;
             cardiac device, congestive heart failure&#xD;
&#xD;
         10. Positive baseline stool culture for LGG&#xD;
&#xD;
         11. Recent or planned chemotherapy or radiation therapy&#xD;
&#xD;
         12. Solid organ transplant within the prior year&#xD;
&#xD;
         13. Stem cell transplant within the prior year&#xD;
&#xD;
         14. On active immunosuppressive medication [anti-rejection, injectable immunosuppressive&#xD;
             drugs for autoimmune disease, or corticosteroids (greater than Â½ mg per kg body weight&#xD;
             of prednisone or its equivalent) not including inhaled or topical steroids]&#xD;
&#xD;
         15. Allergy or intolerance to or contraindication to two or more of the rescue antibiotic&#xD;
             regimens (ampicillin, clindamycin, moxifloxacin)&#xD;
&#xD;
         16. Participating in another clinical trial&#xD;
&#xD;
         17. Uncontrolled psychiatric illness&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shira Doron, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tufts Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tufts Medical Center Weight and Wellness Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <study_first_submitted>May 13, 2013</study_first_submitted>
  <study_first_submitted_qc>June 3, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 6, 2013</study_first_posted>
  <last_update_submitted>February 9, 2016</last_update_submitted>
  <last_update_submitted_qc>February 9, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 10, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>gastric bypass</keyword>
  <keyword>microbiota</keyword>
  <keyword>probiotic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

